Custom Search

Register
Sign In
Sign In Using Facebook

Doubts Over Safety of Drug-coated Stents Hit the Device Makers Hard

August 17, 2007 at 7:27 PM Drug News
  •   Print
  •   Share
  •   Comments
  •  Text 
Doubts Over Safety of Drug-coated Stents Hit the Device Makers Hard
Once hailed as a sure-fire device against clogging, the drug-coated stents have steadily come down in popularity charts. Their sales have nosedived, hitting hard the finances of the device makers.


Johnson & Johnson is cutting nearly 5,000 jobs due in part to a stent decline after studies questioned the devices' safety and effectiveness in preventing heart attacks and bypass surgery. Boston Scientific is preparing its own cuts after its stock hit a five-year low and its credit rating sank below junk-bond status.

The industry hopes to resurrect the market by rolling out next-generation versions of stents, metal-mesh tubes about the size of an ink pen spring that unfold inside coronary arteries like a scaffold. Although the new stents are designed to be safer and more effective, industry analysts don't expect a quick turnaround.

"I'm not going to be so bold as to call this the bottom in the market yet, but we're close, in this country," said Thom Gunderson, a Piper Jaffray analyst. "I think in three or four quarters going forward, you'll see a rebound."

Fellow Piper Jaffray analyst Timothy Nelson and Millennium Research Group stent analyst Bina Mistry both said in interviews that they project the U.S. drug-coated stent market to shrink from about $2.9 billion last year to roughly $2 billion this year. They haven't done projections on the global decline.

It's been a quick turnaround for a market that emerged after J&J introduced the first U.S. drug-coated stent in 2003, and Boston Scientific followed with its own the next year.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Be the first to comment!
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  

X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Child Health Center

Drug Related News

» Weight Loss Drug Has Killed At Least 1,300 in France » FDA Approves Sanofi’s Treatment for Head Lice
» New Scoring Method may Help Decide Who Will Benefit From Stroke Drug » New Guidelines Recommend Metformin to Treat Type 2 Diabetes
» Novel Prostate Cancer Drug Target Identified » Aspirin Helps Prevent DVT
» Amgen's Xgeva to be Probed by FDA Panel » FDA Takes a Closer Look at Dietary Supplements
Read More >>